Nu Skin Enterprises Inc. (NUS)
Nu Skin Enterprises Statistics
Share Statistics
Nu Skin Enterprises has 49.72M shares outstanding. The number of shares has increased by -0.5% in one year.
Shares Outstanding | 49.72M |
Shares Change (YoY) | -0.5% |
Shares Change (QoQ) | 0.02% |
Owned by Institutions (%) | 75.7% |
Shares Floating | 47.87M |
Failed to Deliver (FTD) Shares | 843 |
FTD / Avg. Volume | 0.11% |
Short Selling Information
The latest short interest is 2.34M, so 4.71% of the outstanding shares have been sold short.
Short Interest | 2.34M |
Short % of Shares Out | 4.71% |
Short % of Float | 4.82% |
Short Ratio (days to cover) | 2.46 |
Valuation Ratios
The PE ratio is -2.33 and the forward PE ratio is 8.22. Nu Skin Enterprises's PEG ratio is 0.
PE Ratio | -2.33 |
Forward PE | 8.22 |
PS Ratio | 0.2 |
Forward PS | 0.3 |
PB Ratio | 0.53 |
P/FCF Ratio | 4.88 |
PEG Ratio | 0 |
Enterprise Valuation
Nu Skin Enterprises Inc. has an Enterprise Value (EV) of 1.57B.
EV / Earnings | -10.73 |
EV / Sales | 0.91 |
EV / EBITDA | -10.38 |
EV / EBIT | -10.38 |
EV / FCF | 22.42 |
Financial Position
The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.69.
Current Ratio | 1.82 |
Quick Ratio | 1.17 |
Debt / Equity | 0.69 |
Total Debt / Capitalization | 40.97 |
Cash Flow / Debt | 0.25 |
Interest Coverage | -5.74 |
Financial Efficiency
Return on equity (ROE) is -0.23% and return on capital (ROIC) is -11.5%.
Return on Equity (ROE) | -0.23% |
Return on Assets (ROA) | -0.1% |
Return on Capital (ROIC) | -11.5% |
Revenue Per Employee | $558,736.77 |
Profits Per Employee | $-47,288.39 |
Employee Count | 3,100 |
Asset Turnover | 1.18 |
Inventory Turnover | 2.89 |
Taxes
Income Tax | -28.46M |
Effective Tax Rate | 0.16 |
Stock Price Statistics
The stock price has increased by -47.94% in the last 52 weeks. The beta is 1.04, so Nu Skin Enterprises's price volatility has been higher than the market average.
Beta | 1.04 |
52-Week Price Change | -47.94% |
50-Day Moving Average | 7.35 |
200-Day Moving Average | 8.11 |
Relative Strength Index (RSI) | 44.49 |
Average Volume (20 Days) | 771.75K |
Income Statement
In the last 12 months, Nu Skin Enterprises had revenue of 1.73B and earned -146.59M in profits. Earnings per share was -2.95.
Revenue | 1.73B |
Gross Profit | 1.18B |
Operating Income | -151.59M |
Net Income | -146.59M |
EBITDA | -151.59M |
EBIT | -151.59M |
Earnings Per Share (EPS) | -2.95 |
Balance Sheet
The company has 186.88M in cash and 452.05M in debt, giving a net cash position of -265.17M.
Cash & Cash Equivalents | 186.88M |
Total Debt | 452.05M |
Net Cash | -265.17M |
Retained Earnings | 1.71B |
Total Assets | 1.47B |
Working Capital | 241.99M |
Cash Flow
In the last 12 months, operating cash flow was 111.74M and capital expenditures -41.58M, giving a free cash flow of 70.16M.
Operating Cash Flow | 111.74M |
Capital Expenditures | -41.58M |
Free Cash Flow | 70.16M |
FCF Per Share | 1.41 |
Margins
Gross margin is 68.23%, with operating and profit margins of -8.75% and -8.46%.
Gross Margin | 68.23% |
Operating Margin | -8.75% |
Pretax Margin | -10.11% |
Profit Margin | -8.46% |
EBITDA Margin | -8.75% |
EBIT Margin | -8.75% |
FCF Margin | 4.05% |
Dividends & Yields
NUS pays an annual dividend of $0.3, which amounts to a dividend yield of 3.14%.
Dividend Per Share | $0.30 |
Dividend Yield | 3.14% |
Dividend Growth (YoY) | 0% |
Payout Ratio | -10.17% |
Earnings Yield | -40.97% |
FCF Yield | 19.6% |
Analyst Forecast
The average price target for NUS is $6.88, which is -4.4% lower than the current price. The consensus rating is "Hold".
Price Target | $6.88 |
Price Target Difference | -4.4% |
Analyst Consensus | Hold |
Analyst Count | 2 |
Scores
Altman Z-Score | 2.94 |
Piotroski F-Score | 4 |